Loading...
Header Logo
Keywords
Last Name
Institution

Professor William Charman

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rueda P, Harley E, Lu Y, Stewart GD, Fabb S, Diepenhorst N, Cremers B, Rouillon MH, Wehrle I, Geant A, Lamarche G, Leach K, Charman WN, Christopoulos A, Summers RJ, Sexton PM, Langmead CJ. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants. PLoS One. 2016; 11(1):e0146846. PMID: 26785252.
      View in: PubMed
    2. Atchison DA, Blazaki S, Suheimat M, Plainis S, Charman WN. Do small-aperture presbyopic corrections influence the visual field? Ophthalmic Physiol Opt. 2016 Jan; 36(1):51-9. PMID: 26769327.
      View in: PubMed
    3. Davies LN, Croft MA, Papas E, Charman WN. Presbyopia: physiology, prevention and pathways to correction. Ophthalmic Physiol Opt. 2016 Jan; 36(1):1-4. PMID: 26769325.
      View in: PubMed
    4. Charman WN. Myopia revisited, 2010-2015. Ophthalmic Physiol Opt. 2015 Nov; 35(6):637-42. PMID: 26497297.
      View in: PubMed
    5. Radhakrishnan H, Hartwig A, Charman WN, Llorente L. Accommodation response to Chinese and Latin characters in Chinese-illiterate young adults. Clin Exp Optom. 2015 Nov; 98(6):527-34. PMID: 26450168.
      View in: PubMed
    6. Charman WN, Heron G. Microfluctuations in accommodation: an update on their characteristics and possible role. Ophthalmic Physiol Opt. 2015 Sep; 35(5):476-99. PMID: 26303445.
      View in: PubMed
    7. Riddy DM, Valant C, Rueda P, Charman WN, Sexton PM, Summers RJ, Christopoulos A, Langmead CJ. Label-Free Kinetics: Exploiting Functional Hemi-Equilibrium to Derive Rate Constants for Muscarinic Receptor Antagonists. Mol Pharmacol. 2015 Oct; 88(4):779-90. PMID: 26243731.
      View in: PubMed
    8. Hartwig A, Charman WN, Radhakrishnan H. Baseline peripheral refractive error and changes in axial refraction during one year in a young adult population. J Optom. 2016 Jan-Mar; 9(1):32-9. PMID: 26188389.
      View in: PubMed
    9. Plainis S, Charman WN. Problems in comparisons of data for the prevalence of myopia and the frequency distribution of ametropia. Ophthalmic Physiol Opt. 2015 Jul; 35(4):394-404. PMID: 25959139.
      View in: PubMed
    10. Simpson MJ, Charman WN. The effect of testing distance on intraocular lens power calculation. J Refract Surg. 2014 Nov; 30(11):726. PMID: 25375842.
      View in: PubMed
    11. Atchison DA, Mathur A, Suheimat M, Charman WN. Visual field coordinates of pupillary circular axis and optical axis. Optom Vis Sci. 2014 May; 91(5):582-7. PMID: 24727827.
      View in: PubMed
    12. Charman WN. Developments in the correction of presbyopia II: surgical approaches. Ophthalmic Physiol Opt. 2014 Jul; 34(4):397-426. PMID: 24716827.
      View in: PubMed
    13. Mountford SJ, Albiston AL, Charman WN, Ng L, Holien JK, Parker MW, Nicolazzo JA, Thompson PE, Chai SY. Synthesis, structure-activity relationships and brain uptake of a novel series of benzopyran inhibitors of insulin-regulated aminopeptidase. J Med Chem. 2014 Feb 27; 57(4):1368-77. PMID: 24471437.
      View in: PubMed
    14. Han S, Quach T, Hu L, Wahab A, Charman WN, Stella VJ, Trevaskis NL, Simpson JS, Porter CJ. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies. J Control Release. 2014 Mar 10; 177:1-10. PMID: 24398334.
      View in: PubMed
    15. Atchison DA, Charman WN. Influence of stop position on spectacle magnification. Optom Vis Sci. 2014 Jan; 91(1):97-102. PMID: 24270640.
      View in: PubMed
    16. Charman WN, Atchison DA. Age-dependence of the average and equivalent refractive indices of the crystalline lens. Biomed Opt Express. 2013 Dec 02; 5(1):31-9. PMID: 24466474.
      View in: PubMed
    17. Charman WN. Developments in the correction of presbyopia I: spectacle and contact lenses. Ophthalmic Physiol Opt. 2014 Jan; 34(1):8-29. PMID: 24205890.
      View in: PubMed
    18. Charman WN, Heron G, Whiteley A. Winners in the 2012 Naylor prize competition. Ophthalmic Physiol Opt. 2013 Nov; 33(6):675-6. PMID: 24118037.
      View in: PubMed
    19. Plainis S, Petratou D, Giannakopoulou T, Radhakrishnan H, Pallikaris IG, Charman WN. Small-aperture monovision and the Pulfrich experience: absence of neural adaptation effects. PLoS One. 2013; 8(10):e75987. PMID: 24155881.
      View in: PubMed
    20. Plainis S, Atchison DA, Charman WN. Power profiles of multifocal contact lenses and their interpretation. Optom Vis Sci. 2013 Oct; 90(10):1066-77. PMID: 23995515.
      View in: PubMed
    21. Hartwig A, Gowen E, Charman WN, Radhakrishnan H. Binocular saccades in myopes and emmetropes. Optom Vis Sci. 2013 Sep; 90(9):980-7. PMID: 23912966.
      View in: PubMed
    22. Persson LC, Porter CJ, Charman WN, Bergström CA. Computational prediction of drug solubility in lipid based formulation excipients. Pharm Res. 2013 Dec; 30(12):3225-37. PMID: 23771564.
      View in: PubMed
    23. Yeap YY, Trevaskis NL, Quach T, Tso P, Charman WN, Porter CJ. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation. Mol Pharm. 2013 May 06; 10(5):1874-89. PMID: 23480483.
      View in: PubMed
    24. Trevaskis NL, Caliph SM, Nguyen G, Tso P, Charman WN, Porter CJ. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport. Pharm Res. 2013 Dec; 30(12):3254-70. PMID: 23430484.
      View in: PubMed
    25. Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJ. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013 Jan; 65(1):315-499. PMID: 23383426.
      View in: PubMed
    26. Plainis S, Petratou D, Giannakopoulou T, Radhakrishnan H, Pallikaris IG, Charman WN. Interocular differences in visual latency induced by reduced-aperture monovision. Ophthalmic Physiol Opt. 2013 Mar; 33(2):123-9. PMID: 23278194.
      View in: PubMed
    27. Huntjens B, Charman WN, Workman H, Hosking SL, O'Donnell C. Short-term stability in refractive status despite large fluctuations in glucose levels in diabetes mellitus type 1 and 2. PLoS One. 2012; 7(12):e52947. PMID: 23285232.
      View in: PubMed
    28. Plainis S, Ntzilepis G, Atchison DA, Charman WN. Through-focus performance with multifocal contact lenses: effect of binocularity, pupil diameter and inherent ocular aberrations. Ophthalmic Physiol Opt. 2013 Jan; 33(1):42-50. PMID: 23199097.
      View in: PubMed
    29. Charman WN. Gradients of refractive index in the crystalline lens and transient changes in refraction among patients with diabetes. Biomed Opt Express. 2012 Dec 01; 3(12):3033-42. PMID: 23243557.
      View in: PubMed
    30. Yuthavong Y, Tarnchompoo B, Vilaivan T, Chitnumsub P, Kamchonwongpaisan S, Charman SA, McLennan DN, White KL, Vivas L, Bongard E, Thongphanchang C, Taweechai S, Vanichtanankul J, Rattanajak R, Arwon U, Fantauzzi P, Yuvaniyama J, Charman WN, Matthews D. Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proc Natl Acad Sci U S A. 2012 Oct 16; 109(42):16823-8. PMID: 23035243.
      View in: PubMed
    31. Charman WN. Optical modelling of the possible origins of transient refractive changes in diabetic patients. Ophthalmic Physiol Opt. 2012 Nov; 32(6):485-91. PMID: 22958271.
      View in: PubMed
    32. Davis RA, Buchanan MS, Duffy S, Avery VM, Charman SA, Charman WN, White KL, Shackleford DM, Edstein MD, Andrews KT, Camp D, Quinn RJ. Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp. J Med Chem. 2012 Jun 28; 55(12):5851-8. PMID: 22686608.
      View in: PubMed
    33. Oliyai R, Brewster ME, Ozeki T, Rajewski RA, Charman W. Professor Valentino J. Stella: scientist, mentor, entrepreneur, family man, and giant in pharmaceutical chemistry. J Pharm Sci. 2012 Sep; 101(9):2989-95. PMID: 22648793.
      View in: PubMed
    34. Caliph SM, Trevaskis NL, Charman WN, Porter CJ. Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies. J Pharm Sci. 2012 Sep; 101(9):3540-6. PMID: 22623170.
      View in: PubMed
    35. García-Lázaro S, Ferrer-Blasco T, Radhakrishnan H, Cerviño A, Charman WN, Montés-Micó R. Visual function through 4 contact lens-based pinhole systems for presbyopia. J Cataract Refract Surg. 2012 May; 38(5):858-65. PMID: 22424803.
      View in: PubMed
    36. Charman WN, Mathur A, Scott DH, Hartwig A, Atchison DA. Specifying peripheral aberrations in visual science. J Biomed Opt. 2012 Feb; 17(2):025004. PMID: 22463030.
      View in: PubMed
    37. Trevaskis NL, Charman WN, Porter CJ. Correction to "targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?". Mol Pharm. 2011 Dec 05; 8(6):2484. PMID: 21995681.
      View in: PubMed
    38. Montés-Micó R, Madrid-Costa D, Radhakrishnan H, Charman WN, Ferrer-Blasco T. Accommodative functions with multifocal contact lenses: a pilot study. Optom Vis Sci. 2011 Aug; 88(8):998-1004. PMID: 21552179.
      View in: PubMed
    39. Hartwig A, Gowen E, Charman WN, Radhakrishnan H. Working distance and eye and head movements during near work in myopes and non-myopes. Clin Exp Optom. 2011 Nov; 94(6):536-44. PMID: 21762395.
      View in: PubMed
    40. Coteron JM, Marco M, Esquivias J, Deng X, White KL, White J, Koltun M, El Mazouni F, Kokkonda S, Katneni K, Bhamidipati R, Shackleford DM, Angulo-Barturen I, Ferrer SB, Jiménez-Díaz MB, Gamo FJ, Goldsmith EJ, Charman WN, Bathurst I, Floyd D, Matthews D, Burrows JN, Rathod PK, Charman SA, Phillips MA. Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J Med Chem. 2011 Aug 11; 54(15):5540-61. PMID: 21696174.
      View in: PubMed
    41. Hartwig A, Gowen E, Charman WN, Radhakrishnan H. Analysis of head position used by myopes and emmetropes when performing a near-vision reading task. Vision Res. 2011 Jul 15; 51(14):1712-7. PMID: 21663755.
      View in: PubMed
    42. Trevaskis NL, Charman WN, Porter CJ. Acute hypertriglyceridemia promotes intestinal lymphatic lipid and drug transport: a positive feedback mechanism in lipid and drug absorption. Mol Pharm. 2011 Aug 01; 8(4):1132-9. PMID: 21604764.
      View in: PubMed
    43. Plakitsi A, O'Donnell C, Miranda MA, Charman WN, Radhakrishnan H. Corneal biomechanical properties measured with the Ocular Response Analyser in a myopic population. Ophthalmic Physiol Opt. 2011 Jul; 31(4):404-12. PMID: 21615446.
      View in: PubMed
    44. Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Deng X, Charman WN, Bathurst I, Burrows J, Floyd DM, Matthews D, Buckner FS, Charman SA, Phillips MA, Rathod PK. Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem. 2011 Jun 09; 54(11):3935-49. PMID: 21517059.
      View in: PubMed
    45. Atchison DA, Charman WN. Can partial coherence interferometry be used to determine retinal shape? Optom Vis Sci. 2011 May; 88(5):E601-7. PMID: 21399555.
      View in: PubMed
    46. Atchison DA, Charman WN. Thomas Young's investigations in gradient-index optics. Optom Vis Sci. 2011 May; 88(5):E580-4. PMID: 21378590.
      View in: PubMed
    47. Charman WN. Myopia, posture and the visual environment. Ophthalmic Physiol Opt. 2011 Sep; 31(5):494-501. PMID: 21410496.
      View in: PubMed
    48. Charman WN. Keeping the world in focus: how might this be achieved? Optom Vis Sci. 2011 Mar; 88(3):373-6. PMID: 21270674.
      View in: PubMed
    49. Charman SA, Arbe-Barnes S, Bathurst IC, Brun R, Campbell M, Charman WN, Chiu FC, Chollet J, Craft JC, Creek DJ, Dong Y, Matile H, Maurer M, Morizzi J, Nguyen T, Papastogiannidis P, Scheurer C, Shackleford DM, Sriraghavan K, Stingelin L, Tang Y, Urwyler H, Wang X, White KL, Wittlin S, Zhou L, Vennerstrom JL. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci U S A. 2011 Mar 15; 108(11):4400-5. PMID: 21300861.
      View in: PubMed
    50. Atchison DA, Charman WN. Thomas Young's contributions to geometrical optics. Clin Exp Optom. 2011 Jul; 94(4):333-40. PMID: 21214628.
      View in: PubMed
    51. Trevaskis NL, Charman WN, Porter CJ. Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation? Mol Pharm. 2010 Dec 06; 7(6):2297-309. PMID: 20958081.
      View in: PubMed
    52. Hartwig A, Charman WN, Radhakrishnan H. Accommodative response to peripheral stimuli in myopes and emmetropes. Ophthalmic Physiol Opt. 2011 Jan; 31(1):91-9. PMID: 21054470.
      View in: PubMed
    53. Atchison DA, Charman WN. Thomas Young's contribution to visual optics: the Bakerian Lecture "on the mechanism of the eye". J Vis. 2010 Oct 15; 10(12):16. PMID: 21047748.
      View in: PubMed
    54. Trevaskis NL, Shanker RM, Charman WN, Porter CJ. The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles. Pharm Res. 2010 Sep; 27(9):1949-64. PMID: 20635194.
      View in: PubMed
    55. Charman WN, Radhakrishnan H. Peripheral refraction and the development of refractive error: a review. Ophthalmic Physiol Opt. 2010 Jul; 30(4):321-38. PMID: 20629956.
      View in: PubMed
    56. Allen PM, Charman WN, Radhakrishnan H. Changes in dynamics of accommodation after accommodative facility training in myopes and emmetropes. Vision Res. 2010 May 12; 50(10):947-55. PMID: 20304003.
      View in: PubMed
    57. Mathur A, Atchison DA, Charman WN. Effects of age on peripheral ocular aberrations. Opt Express. 2010 Mar 15; 18(6):5840-53. PMID: 20389601.
      View in: PubMed
    58. Trevaskis NL, McEvoy CL, McIntosh MP, Edwards GA, Shanker RM, Charman WN, Porter CJ. The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623). Pharm Res. 2010 May; 27(5):878-93. PMID: 20221896.
      View in: PubMed
    59. Johnstone KD, Karoli T, Liu L, Dredge K, Copeman E, Li CP, Davis K, Hammond E, Bytheway I, Kostewicz E, Chiu FC, Shackleford DM, Charman SA, Charman WN, Harenberg J, Gonda TJ, Ferro V. Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth. J Med Chem. 2010 Feb 25; 53(4):1686-99. PMID: 20128596.
      View in: PubMed
    60. Dong Y, Wittlin S, Sriraghavan K, Chollet J, Charman SA, Charman WN, Scheurer C, Urwyler H, Santo Tomas J, Snyder C, Creek DJ, Morizzi J, Koltun M, Matile H, Wang X, Padmanilayam M, Tang Y, Dorn A, Brun R, Vennerstrom JL. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277). J Med Chem. 2010 Jan 14; 53(1):481-91. PMID: 19924861.
      View in: PubMed
    61. Mathur A, Atchison DA, Charman WN. Effect of accommodation on peripheral ocular aberrations. J Vis. 2009 Nov 24; 9(12):20.1-11. PMID: 20053111.
      View in: PubMed
    62. Tang Y, Wittlin S, Charman SA, Chollet J, Chiu FC, Morizzi J, Johnson LM, Tomas JS, Scheurer C, Snyder C, Zhou L, Dong Y, Charman WN, Matile H, Urwyler H, Dorn A, Vennerstrom JL. The comparative antimalarial properties of weak base and neutral synthetic ozonides. Bioorg Med Chem Lett. 2010 Jan 15; 20(2):563-6. PMID: 19962893.
      View in: PubMed
    63. Mathur A, Atchison DA, Charman WN. Myopia and peripheral ocular aberrations. J Vis. 2009 Sep 21; 9(10):15.1-12. PMID: 19810796.
      View in: PubMed
    64. White KL, Nguyen G, Charman WN, Edwards GA, Faassen WA, Porter CJ. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU. J Pharmacol Exp Ther. 2009 Nov; 331(2):700-9. PMID: 19696095.
      View in: PubMed
    65. Atchison DA, Guo H, Charman WN, Fisher SW. Blur limits for defocus, astigmatism and trefoil. Vision Res. 2009 Sep; 49(19):2393-403. PMID: 19631683.
      View in: PubMed
    66. Creek DJ, Ryan E, Charman WN, Chiu FC, Prankerd RJ, Vennerstrom JL, Charman SA. Stability of peroxide antimalarials in the presence of human hemoglobin. Antimicrob Agents Chemother. 2009 Aug; 53(8):3496-500. PMID: 19487440.
      View in: PubMed
    67. Charman WN, Atchison DA. Decentred optical axes and aberrations along principal visual field meridians. Vision Res. 2009 Jul; 49(14):1869-76. PMID: 19426752.
      View in: PubMed
    68. Charman WN. Physiological optics in 2008: standing on Helmholtz's shoulders. Ophthalmic Physiol Opt. 2009 May; 29(3):209-10. PMID: 19422550.
      View in: PubMed
    69. Holloway GA, Charman WN, Fairlamb AH, Brun R, Kaiser M, Kostewicz E, Novello PM, Parisot JP, Richardson J, Street IP, Watson KG, Baell JB. Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity. Antimicrob Agents Chemother. 2009 Jul; 53(7):2824-33. PMID: 19364854.
      View in: PubMed
    70. Gujjar R, Marwaha A, El Mazouni F, White J, White KL, Creason S, Shackleford DM, Baldwin J, Charman WN, Buckner FS, Charman S, Rathod PK, Phillips MA. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. J Med Chem. 2009 Apr 09; 52(7):1864-72. PMID: 19296651.
      View in: PubMed
    71. Trevaskis NL, Shackleford DM, Charman WN, Edwards GA, Gardin A, Appel-Dingemanse S, Kretz O, Galli B, Porter CJ. Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism. Pharm Res. 2009 Jun; 26(6):1486-95. PMID: 19280324.
      View in: PubMed
    72. Taylor J, Charman WN, O'Donnell C, Radhakrishnan H. Effect of target spatial frequency on accommodative response in myopes and emmetropes. J Vis. 2009 Jan 15; 9(1):16.1-14. PMID: 19271886.
      View in: PubMed
    73. Charman WN, Radhakrishnan H. Accommodation, pupil diameter and myopia. Ophthalmic Physiol Opt. 2009 Jan; 29(1):72-9. PMID: 19154283.
      View in: PubMed
    74. Marriott JL, Nation RL, Roller L, Costelloe M, Galbraith K, Stewart P, Charman WN. Pharmacy education in the context of Australian practice. Am J Pharm Educ. 2008 Dec 15; 72(6):131. PMID: 19325951.
      View in: PubMed
    75. Creek DJ, Chalmers DK, Charman WN, Duke BJ. Quantum chemical study of the intermediate complex required for iron-mediated reactivity and antimalarial activity of dispiro-1,2,4-trioxolanes. J Mol Graph Model. 2008 Oct; 27(3):394-400. PMID: 18693050.
      View in: PubMed
    76. Charman WN, Atchison DA. Optimal spherical focus in the peripheral retina. Ophthalmic Physiol Opt. 2008 May; 28(3):269-76. PMID: 18426427.
      View in: PubMed
    77. Montés-Micó R, Ferrer-Blasco T, Charman WN, Cerviño A, Alfonso JF, Fernández-Vega L. Optical quality of the eye after lens replacement with a pseudoaccommodating intraocular lens. J Cataract Refract Surg. 2008 May; 34(5):763-8. PMID: 18471630.
      View in: PubMed
    78. Charman WN. The eye in focus: accommodation and presbyopia. Clin Exp Optom. 2008 May; 91(3):207-25. PMID: 18336584.
      View in: PubMed
    79. Charman WN, Montés-Micó R, Radhakrishnan H. Problems in the measurement of wavefront aberration for eyes implanted with diffractive bifocal and multifocal intraocular lenses. J Refract Surg. 2008 03; 24(3):280-6. PMID: 18416263.
      View in: PubMed
    80. Creek DJ, Charman WN, Chiu FC, Prankerd RJ, Dong Y, Vennerstrom JL, Charman SA. Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials. Antimicrob Agents Chemother. 2008 Apr; 52(4):1291-6. PMID: 18268087.
      View in: PubMed
    81. Cuiné JF, McEvoy CL, Charman WN, Pouton CW, Edwards GA, Benameur H, Porter CJ. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J Pharm Sci. 2008 Feb; 97(2):995-1012. PMID: 18064698.
      View in: PubMed
    82. Zhou L, Alker A, Ruf A, Wang X, Chiu FC, Morizzi J, Charman SA, Charman WN, Scheurer C, Wittlin S, Dong Y, Hunziker D, Vennerstrom JL. Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277. Bioorg Med Chem Lett. 2008 Mar 01; 18(5):1555-8. PMID: 18262417.
      View in: PubMed
    83. Radhakrishnan H, Charman WN. Peripheral refraction measurement: does it matter if one turns the eye or the head? Ophthalmic Physiol Opt. 2008 Jan; 28(1):73-82. PMID: 18201338.
      View in: PubMed
    84. Charman WN. Foreword. Profiles Drug Subst Excip Relat Methodol. 2007; 33:VII. PMID: 22469142.
      View in: PubMed
    85. Trevaskis NL, Charman WN, Porter CJ. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev. 2008 Mar 17; 60(6):702-16. PMID: 18155316.
      View in: PubMed
    86. Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008 Mar 17; 60(6):673-91. PMID: 18155801.
      View in: PubMed
    87. Creek DJ, Charman WN, Chiu FC, Prankerd RJ, McCullough KJ, Dong Y, Vennerstrom JL, Charman SA. Iron-mediated degradation kinetics of substituted dispiro-1,2,4-trioxolane antimalarials. J Pharm Sci. 2007 Nov; 96(11):2945-56. PMID: 17549767.
      View in: PubMed
    88. Charman WN, Montés-Micó R, Radhakrishnan H. Can we measure wave aberration in patients with diffractive IOLs? J Cataract Refract Surg. 2007 Nov; 33(11):1997. PMID: 17964416.
      View in: PubMed
    89. Radhakrishnan H, Allen PM, Charman WN. Dynamics of accommodative facility in myopes. Invest Ophthalmol Vis Sci. 2007 Sep; 48(9):4375-82. PMID: 17724230.
      View in: PubMed
    90. Atchison DA, Scott DH, Charman WN. Measuring ocular aberrations in the peripheral visual field using Hartmann-Shack aberrometry. J Opt Soc Am A Opt Image Sci Vis. 2007 Sep; 24(9):2963-73. PMID: 17767268.
      View in: PubMed
    91. Charman WN. Results of the 2006 Naylor Prize competition. Ophthalmic Physiol Opt. 2007 Sep; 27(5):518-9. PMID: 17718893.
      View in: PubMed
    92. Kossena GA, Charman WN, Wilson CG, O'Mahony B, Lindsay B, Hempenstall JM, Davison CL, Crowley PJ, Porter CJ. Low dose lipid formulations: effects on gastric emptying and biliary secretion. Pharm Res. 2007 Nov; 24(11):2084-96. PMID: 17657595.
      View in: PubMed
    93. Radhakrishnan H, Charman WN. Age-related changes in static accommodation and accommodative miosis. Ophthalmic Physiol Opt. 2007 Jul; 27(4):342-52. PMID: 17584285.
      View in: PubMed
    94. Radhakrishnan H, Charman WN. Refractive changes associated with oblique viewing and reading in myopes and emmetropes. J Vis. 2007 Jun 13; 7(8):5. PMID: 17685812.
      View in: PubMed
    95. Horne J, d'Auvergne EJ, Coles M, Velkov T, Chin Y, Charman WN, Prankerd R, Gooley PR, Scanlon MJ. Probing the flexibility of the DsbA oxidoreductase from Vibrio cholerae--a 15N - 1H heteronuclear NMR relaxation analysis of oxidized and reduced forms of DsbA. J Mol Biol. 2007 Aug 17; 371(3):703-16. PMID: 17585933.
      View in: PubMed
    96. Radhakrishnan H, Charman WN. Age-related changes in ocular aberrations with accommodation. J Vis. 2007 May 30; 7(7):11.1-21. PMID: 17685807.
      View in: PubMed
    97. Radhakrishnan H, Charman WN. Changes in astigmatism with accommodation. Ophthalmic Physiol Opt. 2007 May; 27(3):275-80. PMID: 17470240.
      View in: PubMed
    98. Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007 Mar; 6(3):231-48. PMID: 17330072.
      View in: PubMed
    99. Cuiné JF, Charman WN, Pouton CW, Edwards GA, Porter CJ. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm Res. 2007 Apr; 24(4):748-57. PMID: 17372700.
      View in: PubMed
    100. Freeman MH, Charman WN. An exploration of modified monovision with diffractive bifocal contact lenses. Cont Lens Anterior Eye. 2007 Jul; 30(3):189-96. PMID: 17289423.
      View in: PubMed
    101. Tang Y, Dong Y, Wittlin S, Charman SA, Chollet J, Chiu FC, Charman WN, Matile H, Urwyler H, Dorn A, Bajpai S, Wang X, Padmanilayam M, Karle JM, Brun R, Vennerstrom JL. Weak base dispiro-1,2,4-trioxolanes: potent antimalarial ozonides. Bioorg Med Chem Lett. 2007 Mar 01; 17(5):1260-5. PMID: 17189686.
      View in: PubMed
    102. Charman WN, Mountford J, Atchison DA, Markwell EL. Peripheral refraction in orthokeratology patients. Optom Vis Sci. 2006 Sep; 83(9):641-8. PMID: 16971842.
      View in: PubMed
    103. Charman WN, Jennings JA. Longitudinal changes in peripheral refraction with age. Ophthalmic Physiol Opt. 2006 Sep; 26(5):447-55. PMID: 16918768.
      View in: PubMed
    104. Padmanilayam M, Scorneaux B, Dong Y, Chollet J, Matile H, Charman SA, Creek DJ, Charman WN, Tomas JS, Scheurer C, Wittlin S, Brun R, Vennerstrom JL. Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1,2,4-trioxolane piperidine. Bioorg Med Chem Lett. 2006 Nov 01; 16(21):5542-5. PMID: 16931006.
      View in: PubMed
    105. Trevaskis NL, Lo CM, Ma LY, Tso P, Irving HR, Porter CJ, Charman WN. An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to rats. Pharm Res. 2006 Aug; 23(8):1786-96. PMID: 16858652.
      View in: PubMed
    106. Dong Y, Tang Y, Chollet J, Matile H, Wittlin S, Charman SA, Charman WN, Tomas JS, Scheurer C, Snyder C, Scorneaux B, Bajpai S, Alexander SA, Wang X, Padmanilayam M, Cheruku SR, Brun R, Vennerstrom JL. Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes. Bioorg Med Chem. 2006 Sep 15; 14(18):6368-82. PMID: 16759871.
      View in: PubMed
    107. Charman WN. The Charles F. Prentice Award Lecture 2005: optics of the human eye: progress and problems. Optom Vis Sci. 2006 Jun; 83(6):335-45. PMID: 16772891.
      View in: PubMed
    108. Sek L, Boyd BJ, Charman WN, Porter CJ. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone. J Pharm Pharmacol. 2006 Jun; 58(6):809-20. PMID: 16734982.
      View in: PubMed
    109. O'Brien C, Charman WN. Relative performance of soft contact lenses having lathe-cut posterior surfaces with and without additional polishing. Cont Lens Anterior Eye. 2006 May; 29(2):101-7. PMID: 16701199.
      View in: PubMed
    110. Trevaskis NL, Tso P, Rider T, Charman WN, Porter CJ, Jandacek R. Tissue uptake of DDT is independent of chylomicron metabolism. Arch Toxicol. 2006 Apr; 80(4):196-200. PMID: 16180009.
      View in: PubMed
    111. Perry CS, Charman SA, Prankerd RJ, Chiu FC, Dong Y, Vennerstrom JL, Charman WN. Chemical kinetics and aqueous degradation pathways of a new class of synthetic ozonide antimalarials. J Pharm Sci. 2006 Apr; 95(4):737-47. PMID: 16435367.
      View in: PubMed
    112. Nicolazzo JA, Charman SA, Charman WN. Methods to assess drug permeability across the blood-brain barrier. J Pharm Pharmacol. 2006 Mar; 58(3):281-93. PMID: 16536894.
      View in: PubMed
    113. Trevaskis NL, Porter CJ, Charman WN. An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat. Drug Metab Dispos. 2006 May; 34(5):729-33. PMID: 16467133.
      View in: PubMed
    114. Charman SA, Perry CS, Chiu FC, McIntosh KA, Prankerd RJ, Charman WN. Alteration of the intravenous pharmacokinetics of a synthetic ozonide antimalarial in the presence of a modified cyclodextrin. J Pharm Sci. 2006 Feb; 95(2):256-67. PMID: 16374851.
      View in: PubMed
    115. Charman WN. Spatial frequency content of the Cardiff and related acuity tests. Ophthalmic Physiol Opt. 2006 Jan; 26(1):5-12. PMID: 16390476.
      View in: PubMed
    116. Perry CS, Charman SA, Prankerd RJ, Chiu FC, Scanlon MJ, Chalmers D, Charman WN. The binding interaction of synthetic ozonide antimalarials with natural and modified beta-cyclodextrins. J Pharm Sci. 2006 Jan; 95(1):146-58. PMID: 16315221.
      View in: PubMed
    117. Atchison DA, Charman WN. Influences of reference plane and direction of measurement on eye aberration measurement. J Opt Soc Am A Opt Image Sci Vis. 2005 Dec; 22(12):2589-97. PMID: 16396018.
      View in: PubMed
    118. Montés-Micó R, Alió JL, Charman WN. Postblink changes in the ocular modulation transfer function measured by a double-pass method. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4468-73. PMID: 16303935.
      View in: PubMed
    119. Leveque NL, Charman WN, Chiu FC. Sensitive method for the quantitative determination of proguanil and its metabolites in rat blood and plasma by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 18; 830(2):314-21. PMID: 16310420.
      View in: PubMed
    120. Trevaskis NL, Porter CJ, Charman WN. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport. J Pharmacol Exp Ther. 2006 Feb; 316(2):881-91. PMID: 16249368.
      View in: PubMed
    121. Trevaskis NL, Porter CJ, Charman WN. Bile increases intestinal lymphatic drug transport in the fasted rat. Pharm Res. 2005 Nov; 22(11):1863-70. PMID: 16132351.
      View in: PubMed
    122. Creek DJ, Chiu FC, Prankerd RJ, Charman SA, Charman WN. Kinetics of iron-mediated artemisinin degradation: effect of solvent composition and iron salt. J Pharm Sci. 2005 Aug; 94(8):1820-9. PMID: 15986470.
      View in: PubMed
    123. Plainis S, Murray IJ, Charman WN. The role of retinal adaptation in night driving. Optom Vis Sci. 2005 Aug; 82(8):682-8. PMID: 16127333.
      View in: PubMed
    124. Dong Y, Chollet J, Matile H, Charman SA, Chiu FC, Charman WN, Scorneaux B, Urwyler H, Santo Tomas J, Scheurer C, Snyder C, Dorn A, Wang X, Karle JM, Tang Y, Wittlin S, Brun R, Vennerstrom JL. Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes. J Med Chem. 2005 Jul 28; 48(15):4953-61. PMID: 16033274.
      View in: PubMed
    125. Charman WN, Atchison DA. Theoretical effect of changes in entrance pupil magnification on wavefront-guided laser refractive corneal surgery. J Refract Surg. 2005 Jul-Aug; 21(4):386-91. PMID: 16128337.
      View in: PubMed
    126. Charman WN. Aberrations and myopia. Ophthalmic Physiol Opt. 2005 Jul; 25(4):285-301. PMID: 15953113.
      View in: PubMed
    127. Naroo SA, Charman WN. Surface roughness after excimer laser ablation using a PMMA model: profilometry and effects on vision. J Refract Surg. 2005 May-Jun; 21(3):260-8. PMID: 15977883.
      View in: PubMed
    128. Montés-Micó R, Alió JL, Charman WN. Dynamic changes in the tear film in dry eyes. Invest Ophthalmol Vis Sci. 2005 May; 46(5):1615-9. PMID: 15851559.
      View in: PubMed
    129. Charman WN. Wavefront technology: past, present and future. Cont Lens Anterior Eye. 2005 Jun; 28(2):75-92. PMID: 16318838.
      View in: PubMed
    130. Kossena GA, Charman WN, Boyd BJ, Porter CJ. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. J Pharm Sci. 2005 Mar; 94(3):481-92. PMID: 15619248.
      View in: PubMed
    131. Ma L, Atchison DA, Charman WN. Off-axis refraction and aberrations following conventional laser in situ keratomileusis. J Cataract Refract Surg. 2005 Mar; 31(3):489-98. PMID: 15811736.
      View in: PubMed
    132. Velkov T, Chuang S, Wielens J, Sakellaris H, Charman WN, Porter CJ, Scanlon MJ. The interaction of lipophilic drugs with intestinal fatty acid-binding protein. J Biol Chem. 2005 May 06; 280(18):17769-76. PMID: 15722357.
      View in: PubMed
    133. Charman WN. Restoring accommodation: a dream or an approaching reality? Ophthalmic Physiol Opt. 2005 Jan; 25(1):1-6. PMID: 15649176.
      View in: PubMed
    134. Heron G, Charman WN. Accommodation as a function of age and the linearity of the response dynamics. Vision Res. 2004 Dec; 44(27):3119-30. PMID: 15482800.
      View in: PubMed
    135. Campbell M, Prankerd RJ, Davie AS, Charman WN. Degradation of berenil (diminazene aceturate) in acidic aqueous solution. J Pharm Pharmacol. 2004 Oct; 56(10):1327-32. PMID: 15482649.
      View in: PubMed
    136. Kossena GA, Charman WN, Boyd BJ, Porter CJ. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs. J Control Release. 2004 Sep 30; 99(2):217-29. PMID: 15380632.
      View in: PubMed
    137. Legras R, Chateau N, Charman WN. Assessment of just-noticeable differences for refractive errors and spherical aberration using visual simulation. Optom Vis Sci. 2004 Sep; 81(9):718-28. PMID: 15365392.
      View in: PubMed
    138. Charman WN. Aniso-accommodation as a possible factor in myopia development. Ophthalmic Physiol Opt. 2004 Sep; 24(5):471-9. PMID: 15315664.
      View in: PubMed
    139. Legras R, Chateau N, Charman WN. A method for simulation of foveal vision during wear of corrective lenses. Optom Vis Sci. 2004 Sep; 81(9):729-38. PMID: 15365393.
      View in: PubMed
    140. Charman WN. Ablation design in relation to spatial frequency, depth-of-focus, and age. J Refract Surg. 2004 Sep-Oct; 20(5):S542-9. PMID: 15523973.
      View in: PubMed
    141. Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FC, Chollet J, Dong Y, Dorn A, Hunziker D, Matile H, McIntosh K, Padmanilayam M, Santo Tomas J, Scheurer C, Scorneaux B, Tang Y, Urwyler H, Wittlin S, Charman WN. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature. 2004 Aug 19; 430(7002):900-4. PMID: 15318224.
      View in: PubMed
    142. Porter CJ, Kaukonen AM, Boyd BJ, Edwards GA, Charman WN. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm Res. 2004 Aug; 21(8):1405-12. PMID: 15359575.
      View in: PubMed
    143. Yousaf M, Hammond NL, Peng J, Wahyuono S, McIntosh KA, Charman WN, Mayer AM, Hamann MT. New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases. J Med Chem. 2004 Jul 01; 47(14):3512-7. PMID: 15214779.
      View in: PubMed
    144. Montés-Micó R, Alió JL, Muñoz G, Charman WN. Temporal changes in optical quality of air-tear film interface at anterior cornea after blink. Invest Ophthalmol Vis Sci. 2004 Jun; 45(6):1752-7. PMID: 15161836.
      View in: PubMed
    145. Porter CJ, Kaukonen AM, Taillardat-Bertschinger A, Boyd BJ, O'Connor JM, Edwards GA, Charman WN. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci. 2004 May; 93(5):1110-21. PMID: 15067688.
      View in: PubMed
    146. Charman WN. Will wavefront aberrometry become a part of routine optometric practice? Clin Exp Optom. 2004 May; 87(3):133-5. PMID: 15186202.
      View in: PubMed
    147. Montés-Micó R, Alió JL, Muñoz G, Pérez-Santonja JJ, Charman WN. Postblink changes in total and corneal ocular aberrations. Ophthalmology. 2004 Apr; 111(4):758-67. PMID: 15051210.
      View in: PubMed
    148. Grellepois F, Chorki F, Ourévitch M, Charneau S, Grellier P, McIntosh KA, Charman WN, Pradines B, Crousse B, Bonnet-Delpon D, Bégué JP. Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin. J Med Chem. 2004 Mar 11; 47(6):1423-33. PMID: 14998331.
      View in: PubMed
    149. McIntosh MP, Charman WN, Campbell M, Porter CJ. Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteins. J Control Release. 2004 Mar 05; 95(2):275-89. PMID: 14980776.
      View in: PubMed
    150. Wolffsohn JS, O'Donnell C, Charman WN, Gilmartin B. Simultaneous continuous recording of accommodation and pupil size using the modified Shin-Nippon SRW-5000 autorefractor. Ophthalmic Physiol Opt. 2004 Mar; 24(2):142-7. PMID: 15005679.
      View in: PubMed
    151. Kossena GA, Charman WN, Boyd BJ, Dunstan DE, Porter CJ. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci. 2004 Feb; 93(2):332-48. PMID: 14705191.
      View in: PubMed
    152. Kaukonen AM, Boyd BJ, Porter CJ, Charman WN. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm Res. 2004 Feb; 21(2):245-53. PMID: 15032305.
      View in: PubMed
    153. Kaukonen AM, Boyd BJ, Charman WN, Porter CJ. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids. Pharm Res. 2004 Feb; 21(2):254-60. PMID: 15032306.
      View in: PubMed
    154. McIntosh MP, Batey AJ, Coker SJ, Porter CJ, Charman WN. Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model. J Pharm Pharmacol. 2004 Jan; 56(1):69-77. PMID: 14980003.
      View in: PubMed
    155. Charman WN. Pupil dilation and wavefront aberration. J Refract Surg. 2004 Jan-Feb; 20(1):87-8. PMID: 14763480.
      View in: PubMed
    156. Montés-Micó R, España E, Bueno I, Charman WN, Menezo JL. Visual performance with multifocal intraocular lenses: mesopic contrast sensitivity under distance and near conditions. Ophthalmology. 2004 Jan; 111(1):85-96. PMID: 14711718.
      View in: PubMed
    157. Charman WN. Restoring accommodation to the presbyopic eye: how do we measure success? J Cataract Refract Surg. 2003 Dec; 29(12):2251-4. PMID: 14709276.
      View in: PubMed
    158. Taillardat-Bertschinger A, Perry CS, Galland A, Prankerd RJ, Charman WN. Partitioning of halofantrine hydrochloride between water, micellar solutions, and soybean oil: Effects on its apparent ionization constant. J Pharm Sci. 2003 Nov; 92(11):2217-28. PMID: 14603507.
      View in: PubMed
    159. Charman WN, Chateau N. The prospects for super-acuity: limits to visual performance after correction of monochromatic ocular aberration. Ophthalmic Physiol Opt. 2003 Nov; 23(6):479-93. PMID: 14622350.
      View in: PubMed
    160. Khoo SM, Shackleford DM, Porter CJ, Edwards GA, Charman WN. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm Res. 2003 Sep; 20(9):1460-5. PMID: 14567642.
      View in: PubMed
    161. Johnson BM, Charman WN, Porter CJ. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A. Drug Metab Dispos. 2003 Sep; 31(9):1151-60. PMID: 12920171.
      View in: PubMed
    162. Holm R, Porter CJ, Edwards GA, Müllertz A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci. 2003 Sep; 20(1):91-7. PMID: 13678797.
      View in: PubMed
    163. Shackleford DM, Faassen WA, Houwing N, Lass H, Edwards GA, Porter CJ, Charman WN. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J Pharmacol Exp Ther. 2003 Sep; 306(3):925-33. PMID: 12807999.
      View in: PubMed
    164. Atchison DA, Scott DH, Charman WN. Hartmann-Shack technique and refraction across the horizontal visual field. J Opt Soc Am A Opt Image Sci Vis. 2003 Jun; 20(6):965-73. PMID: 12801164.
      View in: PubMed
    165. Boyd BJ, Porter CJ, Charman WN. Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion products. J Pharm Sci. 2003 Jun; 92(6):1262-71. PMID: 12761815.
      View in: PubMed
    166. Shackleford DM, Porter CJ, Charman WN. Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo? Biopharm Drug Dispos. 2003 May; 24(4):153-7. PMID: 12698498.
      View in: PubMed
    167. Johnson BM, Chen W, Borchardt RT, Charman WN, Porter CJ. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum. J Pharmacol Exp Ther. 2003 Apr; 305(1):151-8. PMID: 12649363.
      View in: PubMed
    168. Charman WN. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol Opt. 2003 Mar; 23(2):181-7. PMID: 12641706.
      View in: PubMed
    169. McIntosh MP, Batey AJ, Porter CJ, Charman WN, Coker SJ. Desbutylhalofantrine: evaluation of QT prolongation and other cardiovascular effects after intravenous administration in vivo. J Cardiovasc Pharmacol. 2003 Mar; 41(3):406-13. PMID: 12605019.
      View in: PubMed
    170. Kossena GA, Boyd BJ, Porter CJ, Charman WN. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J Pharm Sci. 2003 Mar; 92(3):634-48. PMID: 12587125.
      View in: PubMed
    171. Shackleford DM, Prankerd RJ, Scanlon MJ, Charman WN. Self-micellization of gemfibrozil 1-O-beta acyl glucuronide in aqueous solution. Pharm Res. 2003 Mar; 20(3):465-70. PMID: 12669970.
      View in: PubMed
    172. Charman WN. Mismatch between flap and stromal areas after laser in situ keratomileusis as source of flap striae. J Cataract Refract Surg. 2002 Dec; 28(12):2146-52. PMID: 12498850.
      View in: PubMed
    173. Charman WN, Atchison DA, Scott DH. Theoretical analysis of peripheral imaging after excimer laser corneal refractive surgery for myopia. J Cataract Refract Surg. 2002 Nov; 28(11):2017-25. PMID: 12457679.
      View in: PubMed
    174. Avery MA, Alvim-Gaston M, Vroman JA, Wu B, Ager A, Peters W, Robinson BL, Charman W. Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates. J Med Chem. 2002 Sep 12; 45(19):4321-35. PMID: 12213073.
      View in: PubMed
    175. Heron G, Charman WN, Gray LS. Accommodation dynamics as a function of age. Ophthalmic Physiol Opt. 2002 Sep; 22(5):389-96. PMID: 12358308.
      View in: PubMed
    176. Holm R, Porter CJ, Müllertz A, Kristensen HG, Charman WN. Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharm Res. 2002 Sep; 19(9):1354-61. PMID: 12403073.
      View in: PubMed
    177. Oliveira-Soto L, Charman WN. Some possible longer-term ocular changes following excimer laser refractive surgery. Ophthalmic Physiol Opt. 2002 Jul; 22(4):274-88. PMID: 12162478.
      View in: PubMed
    178. Caldicott A, Charman WN. Diffraction haloes resulting from corneal oedema and epithelial cell size. Ophthalmic Physiol Opt. 2002 May; 22(3):209-13. PMID: 12090635.
      View in: PubMed
    179. Khoo SM, Prankerd RJ, Edwards GA, Porter CJ, Charman WN. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs. J Pharm Sci. 2002 Mar; 91(3):647-59. PMID: 11920750.
      View in: PubMed
    180. Montés-Micó R, Charman WN. Image quality and visual performance in the peripheral visual field following photorefractive keratectomy. J Refract Surg. 2002 Jan-Feb; 18(1):14-22. PMID: 11828902.
      View in: PubMed
    181. Sek L, Porter CJ, Kaukonen AM, Charman WN. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol. 2002 Jan; 54(1):29-41. PMID: 11833493.
      View in: PubMed
    182. Montés-Micó R, Charman WN. Mesopic contrast sensitivity function after excimer laser photorefractive keratectomy. J Refract Surg. 2002 Jan-Feb; 18(1):9-13. PMID: 11828917.
      View in: PubMed
    183. Doherty MM, Charman WN. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clin Pharmacokinet. 2002; 41(4):235-53. PMID: 11978143.
      View in: PubMed
    184. Johnson BM, Charman WN, Porter CJ. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine. AAPS PharmSci. 2002; 4(4):E40. PMID: 12646011.
      View in: PubMed
    185. Hauge E, Naroo SA, Charman WN. Poly(methyl methacrylate) model study of optical surface quality after excimer laser photorefractive keratectomy. J Cataract Refract Surg. 2001 Dec; 27(12):2026-35. PMID: 11738921.
      View in: PubMed
    186. Johnson BM, Charman WN, Porter CJ. The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamil. J Pharm Pharmacol. 2001 Dec; 53(12):1611-9. PMID: 11804391.
      View in: PubMed
    187. Charman WN. Winners in the 2000 Naylor Prize Competition. Ophthalmic Physiol Opt. 2001 Nov; 21(6):490. PMID: 11727878.
      View in: PubMed
    188. Montés-Micó R, Charman WN. Choice of spatial frequency for contrast sensitivity evaluation after corneal refractive surgery. J Refract Surg. 2001 Nov-Dec; 17(6):646-51. PMID: 11758982.
      View in: PubMed
    189. Heron G, Charman WN, Schor CM. Age changes in the interactions between the accommodation and vergence systems. Optom Vis Sci. 2001 Oct; 78(10):754-62. PMID: 11700969.
      View in: PubMed
    190. Khoo SM, Edwards GA, Porter CJ, Charman WN. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine. J Pharm Sci. 2001 Oct; 90(10):1599-607. PMID: 11745718.
      View in: PubMed
    191. Porter CJ, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev. 2001 Oct 01; 50 Suppl 1:S127-47. PMID: 11576699.
      View in: PubMed
    192. Pennie FC, Wood IC, Olsen C, White S, Charman WN. A longitudinal study of the biometric and refractive changes in full-term infants during the first year of life. Vision Res. 2001 Sep; 41(21):2799-810. PMID: 11587728.
      View in: PubMed
    193. Porter CJ, Charman WN. Transport and absorption of drugs via the lymphatic system. Adv Drug Deliv Rev. 2001 Aug 23; 50(1-2):1-2. PMID: 11489330.
      View in: PubMed
    194. Edwards GA, Porter CJ, Caliph SM, Khoo SM, Charman WN. Animal models for the study of intestinal lymphatic drug transport. Adv Drug Deliv Rev. 2001 Aug 23; 50(1-2):45-60. PMID: 11489333.
      View in: PubMed
    195. Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001 Aug 23; 50(1-2):61-80. PMID: 11489334.
      View in: PubMed
    196. Sek L, Porter CJ, Charman WN. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J Pharm Biomed Anal. 2001 Jun; 25(3-4):651-61. PMID: 11377046.
      View in: PubMed
    197. Porter CJ, Charman WN. Lipid-based formulations for oral administration: opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs. J Recept Signal Transduct Res. 2001 May-Aug; 21(2-3):215-57. PMID: 11757684.
      View in: PubMed
    198. Montés-Micó R, Charman WN. Intraocular pressure after excimer laser myopic refractive surgery. Ophthalmic Physiol Opt. 2001 May; 21(3):228-35. PMID: 11396396.
      View in: PubMed
    199. Heron G, Charman WN, Schor C. Dynamics of the accommodation response to abrupt changes in target vergence as a function of age. Vision Res. 2001 Feb; 41(4):507-19. PMID: 11166053.
      View in: PubMed
    200. Kalsi M, Heron G, Charman WN. Changes in the static accommodation response with age. Ophthalmic Physiol Opt. 2001 Jan; 21(1):77-84. PMID: 11220044.
      View in: PubMed
    201. Khoo SM, Porter CJ, Charman WN. The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment. Int J Pharm. 2000 Sep 15; 205(1-2):65-78. PMID: 11000543.
      View in: PubMed
    202. Charman WN, Jennings JA. Does ocular refraction change with ambient temperature? Ophthalmic Physiol Opt. 2000 Sep; 20(5):408-10. PMID: 11045250.
      View in: PubMed
    203. Charman WN. Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. J Pharm Sci. 2000 Aug; 89(8):967-78. PMID: 10906720.
      View in: PubMed
    204. Caliph SM, Charman WN, Porter CJ. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci. 2000 Aug; 89(8):1073-84. PMID: 10906731.
      View in: PubMed
    205. Naroo SA, Charman WN. Changes in posterior corneal curvature after photorefractive keratectomy. J Cataract Refract Surg. 2000 Jun; 26(6):872-8. PMID: 10889434.
      View in: PubMed
    206. Lyons KC, Charman WN, Miller R, Porter CJ. Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion. Int J Pharm. 2000 Apr 10; 199(1):17-28. PMID: 10794923.
      View in: PubMed
    207. Charman WN, Heron G. On the linearity of accommodation dynamics. Vision Res. 2000; 40(15):2057-66. PMID: 10828472.
      View in: PubMed
    208. Heron G, Charman WN, Gray LS. Accommodation responses and ageing. Invest Ophthalmol Vis Sci. 1999 Nov; 40(12):2872-83. PMID: 10549647.
      View in: PubMed
    209. Simon LD, Stella VJ, Charman WN, Charman SA. Mechanisms controlling diffusion and release of model proteins through and from partially esterified hyaluronic acid membranes. J Control Release. 1999 Sep 20; 61(3):267-79. PMID: 10477800.
      View in: PubMed
    210. Krise JP, Charman WN, Charman SA, Stella VJ. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs. J Pharm Sci. 1999 Sep; 88(9):928-32. PMID: 10479356.
      View in: PubMed
    211. Simon LD, Stella VJ, Charman WN, Charman SA. Variation in the diffusion and release of ribonuclease through and from esterified hyaluronic acid membranes: effect of changes in matrix characteristics. J Control Release. 1999 Aug 27; 61(1-2):159-64. PMID: 10469912.
      View in: PubMed
    212. Koh LH, Charman WN. Size constancy and angular size matching in size perception of near objects. Optom Vis Sci. 1999 Apr; 76(4):241-6. PMID: 10333187.
      View in: PubMed
    213. Charman WN. Near vision, lags of accommodation and myopia. Ophthalmic Physiol Opt. 1999 Mar; 19(2):126-33. PMID: 10615448.
      View in: PubMed
    214. McIntosh MP, Porter CJ, Wasan KM, Ramaswamy M, Charman WN. Differences in the lipoprotein binding profile of halofantrine in fed and fasted human or beagle plasma are dictated by the respective masses of core apolar lipoprotein lipid. J Pharm Sci. 1999 Mar; 88(3):378-84. PMID: 10052998.
      View in: PubMed
    215. Wasan KM, Ramaswamy M, McIntosh MP, Porter CJ, Charman WN. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas. J Pharm Sci. 1999 Feb; 88(2):185-90. PMID: 9950636.
      View in: PubMed
    216. Khoo SM, Porter JH, Edwards GA, Charman WN. Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole. J Pharm Sci. 1998 Dec; 87(12):1538-41. PMID: 10189263.
      View in: PubMed
    217. Cheng D, Woo GC, Irving EL, Charman WN, Murray IJ. Scattering properties of Bagolini lenses and their effects on spatial vision. Ophthalmic Physiol Opt. 1998 Sep; 18(5):438-45. PMID: 10023477.
      View in: PubMed
    218. McIntosh KA, Charman SA, Borgen LA, Charman WN. Analytical methods and stability assessment of liquid yeast derived sucrase. J Pharm Biomed Anal. 1998 Sep 01; 17(6-7):1037-45. PMID: 9884193.
      View in: PubMed
    219. Charman WN, Murray IJ, Nacer M, O'Donoghue EP. Theoretical and practical performance of a concentric bifocal intraocular implant lens. Vision Res. 1998 Sep; 38(18):2841-53. PMID: 9775330.
      View in: PubMed
    220. Atchison DA, Smith G, Charman WN. Errors in determining the direction of the visual axis in the presence of defocus. Ophthalmic Physiol Opt. 1998 Sep; 18(5):463-7. PMID: 10023480.
      View in: PubMed
    221. Humberstone AJ, Porter CJ, Edwards GA, Charman WN. Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state. J Pharm Sci. 1998 Aug; 87(8):936-42. PMID: 9687337.
      View in: PubMed
    222. Koh LH, Charman WN. Accommodation to perceived depth in stereotests. Ophthalmic Physiol Opt. 1998 May; 18(3):279-84. PMID: 9829115.
      View in: PubMed
    223. Koh LH, Charman WN. Accommodative responses to anisoaccommodative targets. Ophthalmic Physiol Opt. 1998 May; 18(3):254-62. PMID: 9829112.
      View in: PubMed
    224. FitzGerald GA, Charman WN. Interpretation of Thrombosis Prevention Trial. Lancet. 1998 Apr 18; 351(9110):1206-7. PMID: 9643718.
      View in: PubMed
    225. Charman WN. Imaging in the 21st century. Ophthalmic Physiol Opt. 1998 Mar; 18(2):210-23. PMID: 9692045.
      View in: PubMed
    226. McIntosh KA, Charman WN, Charman SA. The application of capillary electrophoresis for monitoring effects of excipients on protein conformation. J Pharm Biomed Anal. 1998 Feb; 16(6):1097-105. PMID: 9547715.
      View in: PubMed
    227. Humberstone AJ, Cowman AF, Horton J, Charman WN. Effect of altered serum lipid concentrations on the IC50 of halofantrine against Plasmodium falciparum. J Pharm Sci. 1998 Feb; 87(2):256-8. PMID: 9519163.
      View in: PubMed
    228. Plainis S, Charman WN. On-eye power characteristics of soft contact lenses. Optom Vis Sci. 1998 Jan; 75(1):44-54. PMID: 9460786.
      View in: PubMed
    229. Koh LH, Charman WN. A search for differences in size perception of near objects in young myopes corrected by either spectacles or contact lenses. Cont Lens Anterior Eye. 1998; 21(4):115-20. PMID: 16303389.
      View in: PubMed
    230. Charman WN. Vision and driving--a literature review and commentary. Ophthalmic Physiol Opt. 1997 Sep; 17(5):371-91. PMID: 9390364.
      View in: PubMed
    231. Porter CJ, Caliph SM, Charman WN. Differences in pre- and post-prandial plasma lipid profiles affect the extraction efficiency of a model highly lipophilic drug from beagle dog plasma. J Pharm Biomed Anal. 1997 Sep; 16(1):175-80. PMID: 9447565.
      View in: PubMed
    232. Hughes PJ, Charman WN. Rabbit epidural model. Acta Anaesthesiol Scand. 1997 Sep; 41(8):1089-90. PMID: 9311416.
      View in: PubMed
    233. Atchison DA, Charman WN, Woods RL. Subjective depth-of-focus of the eye. Optom Vis Sci. 1997 Jul; 74(7):511-20. PMID: 9293519.
      View in: PubMed
    234. Arumi P, Chauhan K, Charman WN. Accommodation and acuity under night-driving illumination levels. Ophthalmic Physiol Opt. 1997 Jul; 17(4):291-9. PMID: 9390373.
      View in: PubMed
    235. Charman WN, Porter CJ, Mithani S, Dressman JB. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci. 1997 Mar; 86(3):269-82. PMID: 9050793.
      View in: PubMed
    236. Charman WN, Simonet P. Yves Le Grand and the assessment of retinal acuity using interference fringes. Ophthalmic Physiol Opt. 1997 Mar; 17(2):164-8. PMID: 9196682.
      View in: PubMed
    237. Jennings JA, Charman WN. Analytic approximation of the off-axis modulation transfer function of the eye. Vision Res. 1997 Mar; 37(6):697-704. PMID: 9156214.
      View in: PubMed
    238. Plakitsi A, Charman WN. Ocular spherical aberration and theoretical through-focus modulation transfer functions calculated for eyes fitted with two types of varifocal presbyopic contact lens. Cont Lens Anterior Eye. 1997; 20(3):97-106. PMID: 16303355.
      View in: PubMed
    239. Doherty MM, Hughes PJ, Charman SA, Brock KV, Korszniak NV, Charman WN. Biphasic drug absorption from the epidural space of the dog may limit the utility of a slow release medium molecular weight hyaluronic acid-lidocaine ionic complex formulation. Anesth Analg. 1996 Dec; 83(6):1244-50. PMID: 8942594.
      View in: PubMed
    240. Charman WN. Night myopia and driving. Ophthalmic Physiol Opt. 1996 Nov; 16(6):474-85. PMID: 8944194.
      View in: PubMed
    241. Chauhan K, Charman WN. Accommodation responses to flickering stimuli. Ophthalmic Physiol Opt. 1996 Sep; 16(5):391-408. PMID: 8944184.
      View in: PubMed
    242. Humberstone AJ, Porter CJ, Charman WN. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. J Pharm Sci. 1996 May; 85(5):525-9. PMID: 8742945.
      View in: PubMed
    243. Porter CJ, Charman SA, Charman WN. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. J Pharm Sci. 1996 Apr; 85(4):351-6. PMID: 8901067.
      View in: PubMed
    244. Porter CJ, Charman SA, Humberstone AJ, Charman WN. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion. J Pharm Sci. 1996 Apr; 85(4):357-61. PMID: 8901068.
      View in: PubMed
    245. Porter CJ, Charman WN. Model systems for intestinal lymphatic transport studies. Pharm Biotechnol. 1996; 8:85-102. PMID: 8791806.
      View in: PubMed
    246. Charman WN, Jennings JA. Recognition of TNO stereotest figures in the absence of true stereopsis. Optom Vis Sci. 1995 Jul; 72(7):535-6. PMID: 8539019.
      View in: PubMed
    247. Chauhan K, Charman WN. Single figure indices for the steady-state accommodative response. Ophthalmic Physiol Opt. 1995 May; 15(3):217-21. PMID: 7659421.
      View in: PubMed
    248. Doherty MM, Hughes PJ, Korszniak NV, Charman WN. Prolongation of lidocaine-induced epidural anesthesia by medium molecular weight hyaluronic acid formulations: pharmacodynamic and pharmacokinetic studies in the rabbit. Anesth Analg. 1995 Apr; 80(4):740-6. PMID: 7893028.
      View in: PubMed
    249. Humberstone AJ, Currie GJ, Porter CJ, Scanlon MJ, Charman WN. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. J Pharm Biomed Anal. 1995 Mar; 13(3):265-72. PMID: 7619886.
      View in: PubMed
    250. Charman WN. Ultraviolet radiation and cataract. Br J Ophthalmol. 1995 Feb; 79(2):196. PMID: 7696248.
      View in: PubMed
    251. Whitefoot HD, Charman WN. Hyperchromatic lenses as potential aids for the presbyope. Ophthalmic Physiol Opt. 1995 Jan; 15(1):13-22. PMID: 7724214.
      View in: PubMed
    252. Charman WN. Hybrid diffractive-refractive achromatic spectacle lenses. Ophthalmic Physiol Opt. 1994 Oct; 14(4):389-92. PMID: 7845697.
      View in: PubMed
    253. Charman WN, Plakitsi A. Soft contact lenses and corneal astigmatism. CLAO J. 1994 Oct; 20(4):214-8. PMID: 7820915.
      View in: PubMed
    254. Bennett LE, Charman WN, Williams DB, Charman SA. Analysis of bovine immunoglobulin G by capillary gel electrophoresis. J Pharm Biomed Anal. 1994 Sep; 12(9):1103-8. PMID: 7803559.
      View in: PubMed
    255. Pochopin NL, Charman WN, Stella VJ. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone. Drug Metab Dispos. 1994 Sep-Oct; 22(5):770-5. PMID: 7835230.
      View in: PubMed
    256. Jennings JA, Charman WN. Depth resolution in stereoscopic systems. Appl Opt. 1994 Aug 01; 33(22):5192-6. PMID: 20935906.
      View in: PubMed
    257. Drasdo N, Thompson CM, Charman WN. Inconsistencies in models of the human ocular modulation transfer function. Vision Res. 1994 May; 34(10):1247-53. PMID: 8023434.
      View in: PubMed
    258. Charman WN, Rogge MC, Boddy AW, Barr WH, Berger BM. Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profiles. J Clin Pharmacol. 1993 Dec; 33(12):1207-13. PMID: 8126256.
      View in: PubMed
    259. Charman WN, Charman SA, Monkhouse DC, Frisbee SE, Lockhart EA, Weisman S, Fitzgerald GA. Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation. Br J Clin Pharmacol. 1993 Nov; 36(5):470-3. PMID: 12959298.
      View in: PubMed
    260. Charman SA, McCrossin LE, Charman WN. Validation of a peptide map for recombinant porcine growth hormone and application to stability assessment. Pharm Res. 1993 Oct; 10(10):1471-7. PMID: 8272410.
      View in: PubMed
    261. Charman WN. Can diffractive liquid crystal lenses aid presbyopes? Ophthalmic Physiol Opt. 1993 Oct; 13(4):427-9. PMID: 8278200.
      View in: PubMed
    262. Charman SA, Mason KL, Charman WN. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm Res. 1993 Jul; 10(7):954-62. PMID: 8378257.
      View in: PubMed
    263. Hughes PJ, Doherty MM, Charman WN. A rabbit model for the evaluation of epidurally administered local anaesthetic agents. Anaesth Intensive Care. 1993 Jun; 21(3):298-303. PMID: 8342758.
      View in: PubMed
    264. Irving EL, Woo GC, Charman WN. Notch in contrast sensitivity function of optical origin: diffraction effects of acrylic filters. Ophthalmic Physiol Opt. 1993 Apr; 13(2):179-82. PMID: 8265153.
      View in: PubMed
    265. Charman WN, Rogge MC, Boddy AW, Berger BM. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol. 1993 Apr; 33(4):381-6. PMID: 8473554.
      View in: PubMed
    266. McIntyre DA, Charman WN, Murray IJ. Visual safety of quartz linear lamps. Ann Occup Hyg. 1993 Apr; 37(2):191-200. PMID: 8317854.
      View in: PubMed
    267. Charman WN. Explanation for the observation of isogyres in crystalline lenses viewed between crossed polarizers. Ophthalmic Physiol Opt. 1993 Apr; 13(2):209-15. PMID: 8265159.
      View in: PubMed
    268. Charman WN, Voisin L. Optical aspects of tolerances to uncorrected ocular astigmatism. Optom Vis Sci. 1993 Feb; 70(2):111-7. PMID: 8446373.
      View in: PubMed
    269. Lyle WM, Cullen AP, Charman WN. Role of lasers in eye care. Optom Vis Sci. 1993 Feb; 70(2):136-51. PMID: 8446378.
      View in: PubMed
    270. Charman WN, Voisin L. Astigmatism, accommodation, the oblique effect and meridional amblyopia. Ophthalmic Physiol Opt. 1993 Jan; 13(1):73-81. PMID: 8510951.
      View in: PubMed
    271. Charman WN, Humberstone AJ, Charman SA. Analysis of pilocarpine and its degradation products by micellar electrokinetic capillary chromatography. Pharm Res. 1992 Sep; 9(9):1219-23. PMID: 1409408.
      View in: PubMed
    272. Walsh G, Charman WN. Variation in ocular modulation and phase transfer functions with grating orientation. Ophthalmic Physiol Opt. 1992 Jul; 12(3):365-9. PMID: 1454375.
      View in: PubMed
    273. Tang CY, Charman WN. Effects of monochromatic and chromatic oblique aberrations on visual performance during spectacle lens wear. Ophthalmic Physiol Opt. 1992 Jul; 12(3):340-9. PMID: 1454372.
      View in: PubMed
    274. Chauhan K, Charman WN, Halnan AM, Kelly CM, Loughlin A, Neilson KJ, Walsh G. Time-averaged accommodation response to flickering stimuli. Ophthalmic Physiol Opt. 1992 Jul; 12(3):327-34. PMID: 1454370.
      View in: PubMed
    275. Dackson K, Stone JA, Palin KJ, Charman WN. Evaluation of the mass balance assumption with respect to the two-resistance model of intestinal absorption by using in situ single-pass intestinal perfusion of theophylline in rats. J Pharm Sci. 1992 Apr; 81(4):321-5. PMID: 1501064.
      View in: PubMed
    276. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992 Jan; 9(1):87-93. PMID: 1589415.
      View in: PubMed
    277. Whitefoot H, Charman WN. Dynamic retinoscopy and accommodation. Ophthalmic Physiol Opt. 1992 Jan; 12(1):8-17. PMID: 1584622.
      View in: PubMed
    278. FitzGerald GA, Lupinetti M, Charman SA, Charman WN. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2. J Pharmacol Exp Ther. 1991 Dec; 259(3):1043-9. PMID: 1762060.
      View in: PubMed
    279. Morrell A, Whitefoot HD, Charman WN. Ocular chromatic aberration and age. Ophthalmic Physiol Opt. 1991 Oct; 11(4):385-90. PMID: 1771076.
      View in: PubMed
    280. Charman WN, Lai CS, Finnin BC, Reed BL. Self-association of nicotinamide in aqueous solution: mass transport, freezing-point depression, and partition coefficient studies. Pharm Res. 1991 Sep; 8(9):1144-50. PMID: 1838597.
      View in: PubMed
    281. Charman WN. Wavefront aberration of the eye: a review. Optom Vis Sci. 1991 Aug; 68(8):574-83. PMID: 1923333.
      View in: PubMed
    282. FitzGerald GA, Murray R, Moran N, Funk C, Charman W, Clarke R, Furci L, Fitzgerald DJ. Mechanisms of eicosanoid action. Adv Prostaglandin Thromboxane Leukot Res. 1991; 21B:577-81. PMID: 1825381.
      View in: PubMed
    283. Deeley RJ, Drasdo N, Charman WN. A simple parametric model of the human ocular modulation transfer function. Ophthalmic Physiol Opt. 1991 Jan; 11(1):91-3. PMID: 2034461.
      View in: PubMed
    284. Charman WN. Ocular hazards arising from depletion of the natural atmospheric ozone layer: a review. Ophthalmic Physiol Opt. 1990 Oct; 10(4):333-41. PMID: 2263366.
      View in: PubMed
    285. Walsh G, Charman WN. The subjective sensitivity to small changes in the contrast of a suprathreshold grating. Vision Res. 1990; 30(1):163-73. PMID: 2321361.
      View in: PubMed
    286. Walsh G, Charman WN. The effect of defocus on the contrast and phase of the retinal image of a sinusoidal grating. Ophthalmic Physiol Opt. 1989 Oct; 9(4):398-404. PMID: 2631006.
      View in: PubMed
    287. Charman WN. Accommodation performance for chromatic displays. Ophthalmic Physiol Opt. 1989 Oct; 9(4):459-63. PMID: 2631021.
      View in: PubMed
    288. Charman WN. The path to presbyopia: straight or crooked? Ophthalmic Physiol Opt. 1989 Oct; 9(4):424-30. PMID: 2631011.
      View in: PubMed
    289. Charman WN. Symptoms in central serous retinopathy. Ophthalmic Physiol Opt. 1989 Jul; 9(3):340-2. PMID: 2622683.
      View in: PubMed
    290. Ramsdale C, Charman WN. A longitudinal study of the changes in the static accommodation response. Ophthalmic Physiol Opt. 1989 Jul; 9(3):255-63. PMID: 2622665.
      View in: PubMed
    291. Charman WN. Do direct ophthalmoscopes put the patients' eyes at risk? Ophthalmic Physiol Opt. 1989 Jul; 9(3):349. PMID: 2622686.
      View in: PubMed
    292. Winn B, Charman WN, Pugh JR, Heron G, Eadie AS. Perceptual detectability of ocular accommodation microfluctuations. J Opt Soc Am A. 1989 Mar; 6(3):459-62. PMID: 2709192.
      View in: PubMed
    293. Charman WN, Walsh G. Variations in the local refractive correction of the eye across its entrance pupil. Optom Vis Sci. 1989 Jan; 66(1):34-40. PMID: 2927908.
      View in: PubMed
    294. Charman WN. Light on the peripheral retina. Ophthalmic Physiol Opt. 1989 Jan; 9(1):91-2. PMID: 2594388.
      View in: PubMed
    295. Charman WN. A contact lens centenary. Ophthalmic Physiol Opt. 1988; 8(4):465. PMID: 3075731.
      View in: PubMed
    296. Walsh G, Charman WN. Visual sensitivity to temporal change in focus and its relevance to the accommodation response. Vision Res. 1988; 28(11):1207-21. PMID: 3253992.
      View in: PubMed
    297. Ramsdale C, Charman WN. Accommodation and convergence: effects of lenses and prisms in 'closed-loop' conditions. Ophthalmic Physiol Opt. 1988; 8(1):43-52. PMID: 3419828.
      View in: PubMed
    298. Walsh G, Charman WN. The effect of pupil centration and diameter on ocular performance. Vision Res. 1988; 28(5):659-65. PMID: 3195069.
      View in: PubMed
    299. Charman WN, Heron G. Fluctuations in accommodation: a review. Ophthalmic Physiol Opt. 1988; 8(2):153-64. PMID: 3062549.
      View in: PubMed
    300. Morrell A, Charman WN. A bichromatic laser optometer. Am J Optom Physiol Opt. 1987 Oct; 64(10):790-5. PMID: 3688182.
      View in: PubMed
    301. Ward PA, Charman WN. An objective assessment of the effect of fogging on accommodation. Am J Optom Physiol Opt. 1987 Oct; 64(10):762-7. PMID: 3688179.
      View in: PubMed
    302. Charman WN, Farquhar CJ, Finnin BC, Reed BL. Characterization of biopolymers by pyrolysis gas chromatography and multidimensional analysis. Application to synthetic melanins. J Chromatogr. 1987 Feb 13; 388(2):389-96. PMID: 3558655.
      View in: PubMed
    303. Ward PA, Charman WN. On the use of small artificial pupils to open-loop the accommodation system. Ophthalmic Physiol Opt. 1987; 7(2):191-3. PMID: 3658445.
      View in: PubMed
    304. Tucker J, Charman WN. Effect of target content at higher spatial frequencies on the accuracy of the accommodation response. Ophthalmic Physiol Opt. 1987; 7(2):137-42. PMID: 3658436.
      View in: PubMed
    305. Charman WN, Jennings JA. Spectacle prescribing among 10-year-old children. Br J Ophthalmol. 1986 Dec; 70(12):934-5. PMID: 3801374.
      View in: PubMed
    306. Charman WN. Static accommodation and the minimum angle of resolution. Am J Optom Physiol Opt. 1986 Nov; 63(11):915-21. PMID: 3789083.
      View in: PubMed
    307. Tucker J, Charman WN, Ward PA. Modulation dependence of the accommodation response to sinusoidal gratings. Vision Res. 1986; 26(10):1693-707. PMID: 3617510.
      View in: PubMed
    308. Mordi J, Tucker J, Charman WN. Effects of 0.1% cyclopentolate or 10% phenylephrine on pupil diameter and accommodation. Ophthalmic Physiol Opt. 1986; 6(2):221-7. PMID: 3748569.
      View in: PubMed
    309. Tucker J, Charman WN. Depth of focus and accommodation for sinusoidal gratings as a function of luminance. Am J Optom Physiol Opt. 1986 Jan; 63(1):58-70. PMID: 3942190.
      View in: PubMed
    310. Stella VJ, Charman WN, Naringrekar VH. Prodrugs. Do they have advantages in clinical practice? Drugs. 1985 May; 29(5):455-73. PMID: 3891303.
      View in: PubMed
    311. Charman WN. Visual standards for driving. Ophthalmic Physiol Opt. 1985; 5(2):211-20. PMID: 4022652.
      View in: PubMed
    312. Charman WN, Walsh G. The optical phase transfer function of the eye and the perception of spatial phase. Vision Res. 1985; 25(4):619-23. PMID: 4060617.
      View in: PubMed
    313. Ward PA, Charman WN. Effect of pupil size on steady state accommodation. Vision Res. 1985; 25(9):1317-26. PMID: 4072012.
      View in: PubMed
    314. Walsh G, Charman WN. Measurement of the axial wavefront aberration of the human eye. Ophthalmic Physiol Opt. 1985; 5(1):23-31. PMID: 3975042.
      View in: PubMed
    315. Walsh G, Charman WN, Howland HC. Objective technique for the determination of monochromatic aberrations of the human eye. J Opt Soc Am A. 1984 Sep; 1(9):987-92. PMID: 6481506.
      View in: PubMed
    316. Charman WN. Optical characteristics of Transpaseal as a partial occluder. Am J Optom Physiol Opt. 1983 Oct; 60(10):846-50. PMID: 6650656.
      View in: PubMed
    317. Charman WN. Unwanted astigmatism in lenses with a concentric variation in sagittal power. Am J Optom Physiol Opt. 1982 Dec; 59(12):997-1001. PMID: 7158659.
      View in: PubMed
    318. Charman WN, Jennings JA. Ametropia and peripheral refraction. Am J Optom Physiol Opt. 1982 Nov; 59(11):922-3. PMID: 7180937.
      View in: PubMed
    319. Charman WN. Theoretical aspects of concentric varifocal lenses. Ophthalmic Physiol Opt. 1982; 2(1):75-86. PMID: 7088558.
      View in: PubMed
    320. Charman WN. Three-dimensional TV system: addendum. Appl Opt. 1981 Jul 15; 20(14):2326. PMID: 20332944.
      View in: PubMed
    321. Jennings JA, Charman WN. The effects of central and peripheral refraction on critical fusion frequency. Ophthalmic Physiol Opt. 1981; 1(2):91-6. PMID: 7339535.
      View in: PubMed
    322. Jennings JA, Charman WN. Off-axis image quality in the human eye. Vision Res. 1981; 21(4):445-55. PMID: 7269324.
      View in: PubMed
    323. Charman WN. Three-dimensional TV system. Appl Opt. 1981 Jan 01; 20(1):14-6. PMID: 20309059.
      View in: PubMed
    324. Charman WN. Reflection of plane-polarized light by the retina. Br J Physiol Opt. 1980; 34:34-49. PMID: 7260483.
      View in: PubMed
    325. Tucker J, Charman WN. Reaction and response times for accommodation. Am J Optom Physiol Opt. 1979 Aug; 56(8):490-503. PMID: 543495.
      View in: PubMed
    326. Charman WN, Whitefoot H. Speckle motion in laser refraction. II. Experimental. Am J Optom Physiol Opt. 1979 May; 56(5):295-304. PMID: 495686.
      View in: PubMed
    327. Charman WN. Speckle movement in laser refraction. I. Theory. Am J Optom Physiol Opt. 1979 Apr; 56(4):219-27. PMID: 517623.
      View in: PubMed
    328. Charman WN, Jennings JA. Merits of the Gaussian moment in judging optical line spread widths. Vision Res. 1979; 19(7):851-2. PMID: 483608.
      View in: PubMed
    329. Charman WN. Effect of refractive error in visual tests with sinusoidal gratings. Br J Physiol Opt. 1979; 33(2):10-20. PMID: 554724.
      View in: PubMed
    330. Charman WN, Jennings JA. Properties of annular artificial pupils. Vision Res. 1979; 19(8):947-9. PMID: 516467.
      View in: PubMed
    331. Charman WN, Whitefoot H. Astigmatism, accommodation, and visual instrumentation. Appl Opt. 1978 Dec 15; 17(24):3903-10. PMID: 20208633.
      View in: PubMed
    332. Jennings JA, Charman WN. Optical image quality in the peripheral retina. Am J Optom Physiol Opt. 1978 Aug; 55(8):582-90. PMID: 742649.
      View in: PubMed
    333. Charman WN, Tucker J. Accommodation and color. J Opt Soc Am. 1978 Apr; 68(4):459-71. PMID: 671137.
      View in: PubMed
    334. Charman WN, Tucker J. Accommodation as a function of object form. Am J Optom Physiol Opt. 1978 Feb; 55(2):84-92. PMID: 677251.
      View in: PubMed
    335. Charman WN, Jennings JA, Whitefoot H. The refraction of the eye in the relation to spherical aberration and pupil size. Br J Physiol Opt. 1978; 32:78-93. PMID: 737383.
      View in: PubMed
    336. Charman WN, Tucker J. Dependence of accommodation response on the spatial frequency spectrum of the observed object. Vision Res. 1977; 17(1):129-39. PMID: 855197.
      View in: PubMed
    337. Charman WN, Jennings JA. Objective measurements of the longitudinal chromatic aberration of the human eye. Vision Res. 1976; 16(9):999-1005. PMID: 948891.
      View in: PubMed
    338. Charman WN, Evans NC. Possible effects of changes in lens pigmentation on the colour balance of an artist's work. Br J Physiol Opt. 1976; 31(1):23-31. PMID: 1026325.
      View in: PubMed
    339. Charman WN, Jennings JA. The optical quality of the monochromatic retinal image as a function of focus. Br J Physiol Opt. 1976; 31(3):119-34. PMID: 1052436.
      View in: PubMed
    340. Charman WN, Heron G. A simple infra-red optometer for accommodation studies. Br J Physiol Opt. 1975; 30(1):1-12. PMID: 1234525.
      View in: PubMed
    341. Tucker J, Charman WN. The depth-of-focus of the human eye for Snellen letters. Am J Optom Physiol Opt. 1975 Jan; 52(1):3-21. PMID: 1111286.
      View in: PubMed
    342. Charman WN. Some sources of discrepancy between static retinoscopy and subjective refraction. Br J Physiol Opt. 1975; 30(2-4):108-18. PMID: 801599.
      View in: PubMed
    343. Charman WN. On the position of the plane of stationarity in laser refraction. Am J Optom Physiol Opt. 1974 Nov; 51(11):832-8. PMID: 4432906.
      View in: PubMed
    344. Jennings JA, Charman WN. An analytical approximation for the modulation transfer function of the eye. Br J Physiol Opt. 1974; 29(2):64-72. PMID: 4470003.
      View in: PubMed
    345. Charman WN. Letter: Optimal magnification for visual microscopy. J Opt Soc Am. 1974 Jan; 64(1):102-4. PMID: 4813432.
      View in: PubMed
    346. Charman WN, Tucker J. The opitcal system of the goldfish eye. Vision Res. 1973 Jan; 13(1):1-8. PMID: 4681987.
      View in: PubMed
    347. Charman WN. Diffraction and the precision of measurement of corneal and other small radii. Am J Optom Arch Am Acad Optom. 1972 Aug; 49(8):672-80. PMID: 4506673.
      View in: PubMed
    348. Charman WN, Rowlands CM. Visual sensations produced by cosmic ray muons. Nature. 1971 Aug 20; 232(5312):574-5. PMID: 4937506.
      View in: PubMed
    349. Charman WN, Fruin JH, Jelley JV, Haynes RF, Hodgson ER, Scott PF, Shakeshaft JR, Baird GA, Delaney TJ, Lawless BG, Drever RW, Meikle WP. Search for isolated radio pulses from the galactic centre at 151.5 MHz. Nature. 1971 Jul 16; 232(5307):177-8. PMID: 16062903.
      View in: PubMed
    350. Charman WN. After images and ball lightning. Nature. 1971 Apr 30; 230(5296):576. PMID: 4928664.
      View in: PubMed
    351. Charman WN, Dennis JA, Fazio GG, Jelley JV. Visual sensations produced by single fast particles. Nature. 1971 Apr 23; 230(5295):522-4. PMID: 4927751.
      View in: PubMed
    352. Charman WN, Jelley JV, Fruin JH, Hodgson ER, Scott PF, Shakeshaft JR, Baird GA, Delaney T, Lawless BG, Drever RW, Meikle WP, Porter RA, Spencer RE. Spaced receiver observations of radio pulses. Nature. 1970 Oct 24; 228(5269):346-8. PMID: 16058926.
      View in: PubMed
    353. Fazio GG, Jelley JV, Charman WN. Generation of Cherenkov light flashes by cosmic radiation within the eyes of the Apollo astronauts. Nature. 1970 Oct 17; 228(5268):260-4. PMID: 5479522.
      View in: PubMed
    354. Charman WN, White GM. Possible pulsed gamma ray emission from the Crab Nebula pulsar. Nature. 1970 Jun 27; 226(5252):1233. PMID: 16057774.
      View in: PubMed
    355. Charman WN. A simple technique for detectinga periodicity of unknown value in the signal from an astronomical source. Appl Opt. 1968 Dec 01; 7(12):2431-2. PMID: 20069025.
      View in: PubMed
    356. Hewitt AV, Charman WN. The use of a cascade intensifier in coudé spectroscopy. Appl Opt. 1968 Apr 01; 7(4):603-6. PMID: 20068645.
      View in: PubMed
    357. Charman WN. Image intensifiers in microscopy. J R Microsc Soc. 1966 Oct; 86(1):33-49. PMID: 5973418.
      View in: PubMed
    358. CHARMAN WN. VISUAL FACTORS IN SIZE MEASUREMENT BY MICROSCOPY. Opt Acta (Lond). 1963 Apr; 10:129-39. PMID: 14051028.
      View in: PubMed
    Charman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description